EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database

Woo-Hyoung Kang iD, Shin Hwang iD, I-Ji Jeong iD, Deok-Bog Moon iD, Dong-Hwan Jung iD, Gi-Won Song iD, Young-In Yoon iD, Tae-Yong Ha iD, Gil-Chun Park iD

Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-15

DOI: 10.2147/jhc.s625029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Woo-Hyoung Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A simplified prognostic model, the AFP-PIVKA-II (AP) score, was developed to predict outcomes after resection of hepatocellular carcinoma (HCC). Unlike the conventional ADV score, it relies only on serum biomarkers (AFP and PIVKA-II), excluding tumor size.

Methods

This study included 2257 patients who underwent liver resection for HCC, using data from the Korea Liver Cancer Registry (2015-2022). The AP score's ability to predict overall survival (OS) and microvascular invasion (MVI) was evaluated and compared with radiologic and pathologic ADV scores.

Results

Median preoperative AFP and PIVKA-II levels were 9.2 ng/mL and 62 mAU/mL. Increasing AP scores showed consistent association with worse OS (p < 0.001). Kaplan-Meier survival analyses using 1.0 log-, 2.0 log-, and 4.0 log-interval groupings consistently demonstrated a stepwise decline in OS with increasing AP score (all p < 0.001). At 4.0 log intervals, Harrell's c-indices for OS prediction were 0.604 (AP score), 0.681 (radiologic ADV score), and 0.677 (pathologic ADV score). For MVI prediction, the areas under the ROC curve values were 0.705, 0.733, and 0.741, respectively. Although ADV score-based models performed better overall, the AP score showed acceptable predictive ability for post-resection patient survival.

Conclusion

The AP score is a simple, biomarker-based tool for estimating survival after HCC resection. While less accurate than ADV score models, its convenience supports use in settings requiring rapid assessment.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomamicrovascular invasionrecurrenceresectiontumor biology

Autor:innen und Institutionen

  • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Korean Liver Cancer Association, Seoul, Korea.

ORCID-Profile: Woo-Hyoung Kang, Shin Hwang, I-Ji Jeong, Deok-Bog Moon, Dong-Hwan Jung, Gi-Won Song, Young-In Yoon, Tae-Yong Ha, Gil-Chun Park

Zitieren

APA

Kang, W. H., Hwang, S., Jeong, I. J., Moon, D. B., Jung, D. H., Song, G. W., Yoon, Y. I., Ha, T. Y., & Park, G. C. (2026). Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database. Journal of Hepatocellular Carcinoma, Volume 13, 1-15. https://doi.org/10.2147/jhc.s625029

Vancouver

Kang WH, Hwang S, Jeong IJ, Moon DB, Jung DH, Song GW, et al. Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-15. doi:10.2147/jhc.s625029

BibTeX
@article{Kang2026,
  author = {Kang, Woo-Hyoung and Hwang, Shin and Jeong, I-Ji and Moon, Deok-Bog and Jung, Dong-Hwan and Song, Gi-Won and Yoon, Young-In and Ha, Tae-Yong and Park, Gil-Chun},
  title = {Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--15},
  doi = {10.2147/jhc.s625029}
}
Kostenlos starten →